Annual Short Term Debt
$420.00 K
+$35.00 K+9.09%
December 31, 2023
Summary
- As of February 8, 2025, AVTE annual short term debt is $420.00 thousand, with the most recent change of +$35.00 thousand (+9.09%) on December 31, 2023.
- During the last 3 years, AVTE annual short term debt has risen by +$420.00 thousand (+100.00%).
- AVTE annual short term debt is now at all-time high.
Performance
AVTE Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Short Term Debt
$459.00 K
-$16.00 K-3.37%
September 30, 2024
Summary
- As of February 8, 2025, AVTE quarterly short term debt is $459.00 thousand, with the most recent change of -$16.00 thousand (-3.37%) on September 30, 2024.
- Over the past year, AVTE quarterly short term debt has increased by +$39.00 thousand (+9.29%).
- AVTE quarterly short term debt is now -3.37% below its all-time high of $475.00 thousand, reached on June 30, 2024.
Performance
AVTE Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
AVTE Short Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +9.1% | +9.3% |
| 3 y3 years | +100.0% | +9.3% |
| 5 y5 years | - | +9.3% |
AVTE Short Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +118.8% | -3.4% | +139.1% |
| 5 y | 5-year | at high | -100.0% | -3.4% | -100.0% |
| alltime | all time | at high | -100.0% | -3.4% | -100.0% |
Aerovate Therapeutics Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $459.00 K(-3.4%) |
| Jun 2024 | - | $475.00 K(+6.7%) |
| Mar 2024 | - | $445.00 K(+6.0%) |
| Dec 2023 | $420.00 K(+9.1%) | $420.00 K(-6.9%) |
| Sep 2023 | - | $451.00 K(+19.0%) |
| Jun 2023 | - | $379.00 K(+1.6%) |
| Mar 2023 | - | $373.00 K(-3.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $385.00 K(+100.5%) | $385.00 K(+1.6%) |
| Sep 2022 | - | $379.00 K(+9.2%) |
| Jun 2022 | - | $347.00 K(+79.8%) |
| Mar 2022 | - | $193.00 K(+0.5%) |
| Dec 2021 | $192.00 K(>+9900.0%) | $192.00 K(+30.6%) |
| Sep 2021 | - | $147.00 K(>+9900.0%) |
| Dec 2020 | $0.00 | $0.00 |
FAQ
- What is Aerovate Therapeutics annual short term debt?
- What is the all time high annual short term debt for Aerovate Therapeutics?
- What is Aerovate Therapeutics annual short term debt year-on-year change?
- What is Aerovate Therapeutics quarterly short term debt?
- What is the all time high quarterly short term debt for Aerovate Therapeutics?
- What is Aerovate Therapeutics quarterly short term debt year-on-year change?
What is Aerovate Therapeutics annual short term debt?
The current annual short term debt of AVTE is $420.00 K
What is the all time high annual short term debt for Aerovate Therapeutics?
Aerovate Therapeutics all-time high annual short term debt is $420.00 K
What is Aerovate Therapeutics annual short term debt year-on-year change?
Over the past year, AVTE annual short term debt has changed by +$35.00 K (+9.09%)
What is Aerovate Therapeutics quarterly short term debt?
The current quarterly short term debt of AVTE is $459.00 K
What is the all time high quarterly short term debt for Aerovate Therapeutics?
Aerovate Therapeutics all-time high quarterly short term debt is $475.00 K
What is Aerovate Therapeutics quarterly short term debt year-on-year change?
Over the past year, AVTE quarterly short term debt has changed by +$39.00 K (+9.29%)